Kerri R. Thomas

872 total citations
10 papers, 688 citations indexed

About

Kerri R. Thomas is a scholar working on Immunology, Molecular Biology and Oncology. According to data from OpenAlex, Kerri R. Thomas has authored 10 papers receiving a total of 688 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Immunology, 3 papers in Molecular Biology and 3 papers in Oncology. Recurrent topics in Kerri R. Thomas's work include Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (2 papers). Kerri R. Thomas is often cited by papers focused on Immune Cell Function and Interaction (5 papers), T-cell and B-cell Immunology (4 papers) and Immunotherapy and Immune Responses (2 papers). Kerri R. Thomas collaborates with scholars based in United States, Switzerland and United Kingdom. Kerri R. Thomas's co-authors include Daniel Campbell, Shivani Srivastava, Kate S. Smigiel, Elizabeth Richards, Kimberly D. Klonowski, Jan C. Dudda, Meghan A. Koch, Nikole Perdue, Michael Gale and Lomon So and has published in prestigious journals such as The Journal of Experimental Medicine, Immunity and Nature Immunology.

In The Last Decade

Kerri R. Thomas

10 papers receiving 688 citations

Peers

Kerri R. Thomas

IMMUN

ONCOL

EPIDE

GENET

Sebastian Seth Germany

Leyla Develioglu France

Marcella Flores United States

Mary A. Antonysamy United States

Tae Jin Yun United States

Colleen J. Winstead United States

Adrienne Verhoef United Kingdom

Phillip P. Domeier United States

Chinami Hashimura Japan

John T. Crowl United States

Sebastian Seth Germany

Kerri R. Thomas

413 ×0.7

IMMUN

135 ×1.0

ONCOL

58 ×0.6

41 ×0.9

EPIDE

31 ×0.7

GENET

Citations per year, relative to Kerri R. Thomas Kerri R. Thomas (= 1×) peers Sebastian Seth

Countries citing papers authored by Kerri R. Thomas

Since Specialization

Citations

This map shows the geographic impact of Kerri R. Thomas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kerri R. Thomas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kerri R. Thomas more than expected).

Fields of papers citing papers by Kerri R. Thomas

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kerri R. Thomas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kerri R. Thomas. The network helps show where Kerri R. Thomas may publish in the future.

Co-authorship network of co-authors of Kerri R. Thomas

This figure shows the co-authorship network connecting the top 25 collaborators of Kerri R. Thomas. A scholar is included among the top collaborators of Kerri R. Thomas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kerri R. Thomas. Kerri R. Thomas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

10 of 10 papers shown

Camp, Nathan D., Kerri R. Thomas, Peter J. Cook, et al.. (2024). Human plasma cells engineered to secrete bispecifics drive effective in vivo leukemia killing. Molecular Therapy. 32(8). 2676–2691. 3 indexed citations

Killebrew, Justin R, Shannon Okada, Lynn M. Amon, et al.. (2024). Abstract 4062: A novel method for generating regulated cytokine therapeutics: Safety and activity of a conditionally active cLAG3-IL2 capable of delivering IL2 to LAG3+ cells while remaining inert on LAG3- cells. Cancer Research. 84(6_Supplement). 4062–4062. 1 indexed citations

Thomas, Kerri R., Eric J. Allenspach, Nathan D. Camp, et al.. (2021). Activated interleukin-7 receptor signaling drives B-cell acute lymphoblastic leukemia in mice. Leukemia. 36(1). 42–57. 20 indexed citations

Schwerk, Johannes, Frank Soveg, Kerri R. Thomas, et al.. (2019). RNA-binding protein isoforms ZAP-S and ZAP-L have distinct antiviral and immune resolution functions. Nature Immunology. 20(12). 1610–1620. 91 indexed citations

Gorman, Jacquelyn A., Christian Hundhausen, Tanvi Arkatkar, et al.. (2019). The TYK2-P1104A Autoimmune Protective Variant Limits Coordinate Signals Required to Generate Specialized T Cell Subsets. Frontiers in Immunology. 10. 44–44. 41 indexed citations

Chawla, Raghav, Kerri R. Thomas, Tanvi Arkatkar, et al.. (2018). Activated CARD11 accelerates germinal center kinetics, promoting mTORC1 and terminal differentiation. The Journal of Experimental Medicine. 215(9). 2445–2461. 13 indexed citations

Sullivan, Jenna M., et al.. (2016). T cell specific dysregulation of Foxo1 results in spontaneous inflammatory disease. The Journal of Immunology. 196(1_Supplement). 133.38–133.38. 1 indexed citations

Smigiel, Kate S., Elizabeth Richards, Shivani Srivastava, et al.. (2013). CCR7 provides localized access to IL-2 and defines homeostatically distinct regulatory T cell subsets. The Journal of Experimental Medicine. 211(1). 121–136. 310 indexed citations

Smigiel, Kate S., Elizabeth Richards, Kerri R. Thomas, & Dan H. Campbell. (2013). CCR7 coordinates paracrine interleukin-2 cross-talk between central memory and regulatory T cells and controls the homeostatic balance between regulatory T cell subsets (P1065). The Journal of Immunology. 190(Supplement_1). 121.4–121.4. 1 indexed citations

10.

Koch, Meghan A., Kerri R. Thomas, Nikole Perdue, et al.. (2012). T-bet+ Treg Cells Undergo Abortive Th1 Cell Differentiation due to Impaired Expression of IL-12 Receptor β2. Immunity. 37(3). 501–510. 207 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact